[Effects of pyrazinamide and cycloserine therapy of tuberculosis on clinical and functional liver reactions and on certain biological tests].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003523:Cycloserine; D006801:Humans; D008099:Liver / Q000378:metabolism*; D009525:Niacin / Q000031:analogs & derivatives; D009539:Nicotinic Acids; D011718:Pyrazinamide; D014376:Tuberculosis / Q000628:therapy*
D000900:Anti-Bacterial Agents; D009539:Nicotinic Acids; D009525:Niacin; D011718:Pyrazinamide; D003523:Cycloserine
ANTIBIOTICS/therapeutic use; LIVER/metabolism; NICOTINIC ACID/related compounds; TUBERCULOSIS/therapy
Osservazioni sul comportamento clinico e funzionale epatico e su alcuni tests biologici nel trattamento antitubercolare con pirazinamide e cicloserina.